|  Help  |  About  |  Contact Us

Allele : Lrrk2<tm1.1Npa> leucine-rich repeat kinase 2; targeted mutation 1.1, Novartis Pharma AG

Primary Identifier  MGI:5295368 Allele Type  Targeted
Attribute String  Humanized sequence Gene  Lrrk2
Transmission  Germline Strain of Origin  BALB/c
Is Recombinase  false Is Wild Type  false
molecularNote  Exon 41 was replaced with a floxed modified exon 41 with nucleotide substitutions (GGG to TCG) that result in the amino acid substitution of serine for glycine at position 2019 (G2019S), mimicking a mutation found in some late-onset autosomal dominant Parkinson's Disease patients. An FRT-flanked neo cassette inserted downstream of the modified exon 41 was removed by flp-mediated recombination. The predicted protein is kinase enhanced.
  • mutations:
  • Nucleotide substitutions,
  • Insertion
  • synonyms:
  • LRRK2-G2019S,
  • LRRK2-G2019S
Quick Links:
 
Quick Links:
 

1 Feature

Trail: Allele

Genome

0 Expresses

0 Mutation Involves

Phenotype

Mouse alleles --> Mammalian phenotypes (MP terms)

 

Other

2 Carried By

Trail: Allele

0 Driven By

12 Publication categories

Trail: Allele